Maxine Bauzon
Impact in
Papers in
- Co-authors
- Terry Hermiston (14 shared papers)Leonard W. Seymour (3 shared papers)Penelope M. Drake (4 shared papers)David Rabuka (3 shared papers)Irene Kuhn (2 shared papers)André Lieber (2 shared papers)Robyn M. Barfield (4 shared papers)Richard N. Harkins (3 shared papers)
- Journals
- Gene Therapy (3 papers)Blood (3 papers)Molecular Cancer Therapeutics (2 papers)Molecular Therapy — Oncolytics (2 papers)Molecular Therapy (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Maxine Bauzon
24 papers receiving 586 citations
Peers
Comparison fields: 5 of 52
- Genetics 397
- Oncology 361
- Biotechnology 89
- Molecular Biology 303
- Infectious Diseases 69
Countries citing papers authored by Maxine Bauzon
This map shows the geographic impact of Maxine Bauzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxine Bauzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxine Bauzon more than expected).
Fields of papers citing papers by Maxine Bauzon
This network shows the impact of papers produced by Maxine Bauzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxine Bauzon. The network helps show where Maxine Bauzon may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxine Bauzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 153 | |
| 2 | 2001 | 81 | |
| 3 | 2021 | 49 | |
| 4 | 2019 | 46 | |
| 5 | 2017 | 40 | |
| 6 | 2014 | 38 | |
| 7 | 2006 | 36 | |
| 8 | A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38. | 2003 | 27 |
| 9 | 2023 | 20 | |
| 10 | 2016 | 17 | |
| 11 | 2006 | 16 | |
| 12 | 2011 | 14 | |
| 13 | 2020 | 11 | |
| 14 | 2007 | 11 | |
| 15 | 2009 | 9 | |
| 16 | 2016 | 9 | |
| 17 | Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses. | 2008 | 7 |
| 18 | 2023 | 5 | |
| 19 | 2019 | 5 | |
| 20 | 2023 | 3 |
About Maxine Bauzon
Maxine Bauzon is a scholar working on Oncology, Genetics, Molecular Biology, Hematology and Immunology, having authored 25 papers that have together received 606 indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (9 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Hemophilia Treatment and Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Genetics (397 citations), Oncology (361 citations), Biotechnology (89 citations), Molecular Biology (303 citations) and Infectious Diseases (69 citations). Maxine Bauzon has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Terry Hermiston, Leonard W. Seymour, Penelope M. Drake, David Rabuka, Irene Kuhn, André Lieber, Robyn M. Barfield, Richard N. Harkins, Gabor M. Rubanyi and Bin Shen. Their work appears in journals such as Gene Therapy, Blood, Molecular Cancer Therapeutics, Molecular Therapy — Oncolytics and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.